OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351,383 | +17.0% | 91,506 | -0.0% | 0.00% | – |
| Q2 2023 | $300,202 | -36.3% | 91,525 | -49.9% | 0.00% | – |
| Q1 2023 | $471,624 | +177.4% | 182,800 | +100.0% | 0.00% | – |
| Q4 2022 | $170,004 | +0.0% | 91,400 | -1.4% | 0.00% | – |
| Q3 2022 | $170,000 | -16.7% | 92,657 | -2.1% | 0.00% | – |
| Q2 2022 | $204,000 | -31.1% | 94,657 | +0.5% | 0.00% | – |
| Q1 2022 | $296,000 | +9766.7% | 94,213 | +9321.3% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -100.0% | 1,000 | -99.9% | 0.00% | -100.0% |
| Q3 2020 | $9,808,000 | -25.3% | 1,708,646 | -4.1% | 0.00% | 0.0% |
| Q2 2020 | $13,128,000 | +111.3% | 1,781,215 | -14.6% | 0.00% | 0.0% |
| Q1 2020 | $6,213,000 | -28.2% | 2,084,900 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,652,000 | +50.2% | 2,084,900 | +105.2% | 0.00% | 0.0% |
| Q3 2018 | $5,760,000 | -43.8% | 1,015,805 | -22.7% | 0.00% | 0.0% |
| Q2 2018 | $10,248,000 | +4.7% | 1,313,824 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $9,792,000 | -32.7% | 1,385,066 | -6.0% | 0.00% | -50.0% |
| Q4 2017 | $14,547,000 | +5.6% | 1,473,873 | -10.4% | 0.00% | 0.0% |
| Q3 2017 | $13,778,000 | -24.5% | 1,645,045 | -9.4% | 0.00% | 0.0% |
| Q2 2017 | $18,254,000 | – | 1,814,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |